4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-060507
Chief Executive Officer sold 183,333 shares at an average $67.15 ($12,310,119)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-12 | Sale : show line 1 in the form | −23,219 | $66.82 | $1,551,494 | 2,048,684 | D |
| 2019-12-12 | Sale : show line 2 in the form | −58,059 | $67.31 | $3,907,951 | 1,990,625 | D |
| 2019-12-12 | Sale : show line 3 in the form | −10,343 | $68.51 | $708,599 | 1,980,282 | D |
| 2019-12-12 | Sale : show line 4 in the form | −8,379 | $69.41 | $581,586 | 1,971,903 | D |
| 2019-12-13 | Sale : show line 5 in the form | −8,951 | $65.85 | $589,423 | 1,962,952 | D |
| 2019-12-13 | Sale : show line 6 in the form | −45,577 | $66.47 | $3,029,503 | 1,917,375 | D |
| 2019-12-13 | Sale : show line 7 in the form | −25,412 | $67.30 | $1,710,228 | 1,891,963 | D |
| 2019-12-13 | Sale : show line 8 in the form | −3,393 | $68.18 | $231,335 | 1,888,570 | D |
| Open-market sales · 183,333 sh · avg $67.15 · $12,310,119 | ||||||
Loading xslF345X03/doc4.xml…